Table of Contents 1 Market Overview 1.1 Inflammatory Bowel Disease Drugs Introduction 1.2 Market Analysis by Type 1.2.1 Ulcerative Colitis 1.2.2 Crohns Disease 1.2.3 Indeterminate Colitis 1.2.4 Others 1.3 Market Analysis by Applications 1.3.1 Amino-salicylates 1.3.2 Antibiotics 1.3.3 Corticosteroids 1.3.4 Immunomodulators 1.3.5 Biologics 1.3.6 Others 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2013-2023) 1.4.1.2 Canada Market States and Outlook (2013-2023) 1.4.1.3 Mexico Market States and Outlook (2013-2023) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2013-2023) 1.4.2.2 France Market States and Outlook (2013-2023) 1.4.2.3 UK Market States and Outlook (2013-2023) 1.4.2.4 Russia Market States and Outlook (2013-2023) 1.4.2.5 Italy Market States and Outlook (2013-2023) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.3.1 China Market States and Outlook (2013-2023) 1.4.3.2 Japan Market States and Outlook (2013-2023) 1.4.3.3 Korea Market States and Outlook (2013-2023) 1.4.3.4 India Market States and Outlook (2013-2023) 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023) 1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook (2013-2023) 1.4.4.2 Egypt Market States and Outlook (2013-2023) 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023) 1.4.4.4 South Africa Market States and Outlook (2013-2023) 1.4.4.5 Nigeria Market States and Outlook (2013-2023) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Abbott Laboratories 2.1.1 Business Overview 2.1.2 Inflammatory Bowel Disease Drugs Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Abbott Laboratories Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2 Biocon Ltd 2.2.1 Business Overview 2.2.2 Inflammatory Bowel Disease Drugs Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Biocon Ltd Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3 F. Hoffmann-La Roche AG 2.3.1 Business Overview 2.3.2 Inflammatory Bowel Disease Drugs Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 F. Hoffmann-La Roche AG Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4 Johnson and Johnson 2.4.1 Business Overview 2.4.2 Inflammatory Bowel Disease Drugs Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Johnson and Johnson Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5 Mylan Pharmaceuticals Ltd. 2.5.1 Business Overview 2.5.2 Inflammatory Bowel Disease Drugs Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Mylan Pharmaceuticals Ltd. Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6 Novartis AG 2.6.1 Business Overview 2.6.2 Inflammatory Bowel Disease Drugs Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Novartis AG Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.7 Pfizer Inc. 2.7.1 Business Overview 2.7.2 Inflammatory Bowel Disease Drugs Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Pfizer Inc. Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.8 Quest Medical, Inc. 2.8.1 Business Overview 2.8.2 Inflammatory Bowel Disease Drugs Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Quest Medical, Inc. Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.9 Sanofi S.A. 2.9.1 Business Overview 2.9.2 Inflammatory Bowel Disease Drugs Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 Sanofi S.A. Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.10 Takeda Pharmaceutical 2.10.1 Business Overview 2.10.2 Inflammatory Bowel Disease Drugs Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 Takeda Pharmaceutical Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 3 Global Inflammatory Bowel Disease Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017) 3.1 Global Inflammatory Bowel Disease Drugs Sales and Market Share by Manufacturer (2016-2017) 3.2 Global Inflammatory Bowel Disease Drugs Revenue and Market Share by Manufacturer (2016-2017) 3.3 Market Concentration Rate 3.3.1 Top 3 Inflammatory Bowel Disease Drugs Manufacturer Market Share in 2017 3.3.2 Top 6 Inflammatory Bowel Disease Drugs Manufacturer Market Share in 2017 3.4 Market Competition Trend 4 Global Inflammatory Bowel Disease Drugs Market Analysis by Regions 4.1 Global Inflammatory Bowel Disease Drugs Sales, Revenue and Market Share by Regions 4.1.1 Global Inflammatory Bowel Disease Drugs Sales and Market Share by Regions (2013-2018) 4.1.2 Global Inflammatory Bowel Disease Drugs Revenue and Market Share by Regions (2013-2018) 4.2 North America Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) 4.3 Europe Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) 4.4 Asia-Pacific Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) 4.5 South America Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) 4.6 Middle East and Africa Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) 5 North America Inflammatory Bowel Disease Drugs by Countries 5.1 North America Inflammatory Bowel Disease Drugs Sales, Revenue and Market Share by Countries 5.1.1 North America Inflammatory Bowel Disease Drugs Sales and Market Share by Countries (2013-2018) 5.1.2 North America Inflammatory Bowel Disease Drugs Revenue and Market Share by Countries (2013-2018) 5.2 United States Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) 5.3 Canada Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) 5.4 Mexico Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) 6 Europe Inflammatory Bowel Disease Drugs by Countries 6.1 Europe Inflammatory Bowel Disease Drugs Sales, Revenue and Market Share by Countries 6.1.1 Europe Inflammatory Bowel Disease Drugs Sales and Market Share by Countries (2013-2018) 6.1.2 Europe Inflammatory Bowel Disease Drugs Revenue and Market Share by Countries (2013-2018) 6.2 Germany Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) 6.3 UK Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) 6.4 France Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) 6.5 Russia Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) 6.6 Italy Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) 7 Asia-Pacific Inflammatory Bowel Disease Drugs by Countries 7.1 Asia-Pacific Inflammatory Bowel Disease Drugs Sales, Revenue and Market Share by Countries 7.1.1 Asia-Pacific Inflammatory Bowel Disease Drugs Sales and Market Share by Countries (2013-2018) 7.1.2 Asia-Pacific Inflammatory Bowel Disease Drugs Revenue and Market Share by Countries (2013-2018) 7.2 China Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) 7.3 Japan Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) 7.4 Korea Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) 7.5 India Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) 7.6 Southeast Asia Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) 8 South America Inflammatory Bowel Disease Drugs by Countries 8.1 South America Inflammatory Bowel Disease Drugs Sales, Revenue and Market Share by Countries 8.1.1 South America Inflammatory Bowel Disease Drugs Sales and Market Share by Countries (2013-2018) 8.1.2 South America Inflammatory Bowel Disease Drugs Revenue and Market Share by Countries (2013-2018) 8.2 Brazil Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) 8.3 Argentina Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) 8.4 Colombia Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) 9 Middle East and Africa Inflammatory Bowel Disease Drugs by Countries 9.1 Middle East and Africa Inflammatory Bowel Disease Drugs Sales, Revenue and Market Share by Countries 9.1.1 Middle East and Africa Inflammatory Bowel Disease Drugs Sales and Market Share by Countries (2013-2018) 9.1.2 Middle East and Africa Inflammatory Bowel Disease Drugs Revenue and Market Share by Countries (2013-2018) 9.2 Saudi Arabia Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) 9.3 UAE Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) 9.4 Egypt Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) 9.5 Nigeria Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) 9.6 South Africa Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) 10 Global Inflammatory Bowel Disease Drugs Market Segment by Type 10.1 Global Inflammatory Bowel Disease Drugs Sales, Revenue and Market Share by Type (2013-2018) 10.1.1 Global Inflammatory Bowel Disease Drugs Sales and Market Share by Type (2013-2018) 10.1.2 Global Inflammatory Bowel Disease Drugs Revenue and Market Share by Type (2013-2018) 10.2 Ulcerative Colitis Sales Growth and Price 10.2.1 Global Ulcerative Colitis Sales Growth (2013-2018) 10.2.2 Global Ulcerative Colitis Price (2013-2018) 10.3 Crohns Disease Sales Growth and Price 10.3.1 Global Crohns Disease Sales Growth (2013-2018) 10.3.2 Global Crohns Disease Price (2013-2018) 10.4 Indeterminate Colitis Sales Growth and Price 10.4.1 Global Indeterminate Colitis Sales Growth (2013-2018) 10.4.2 Global Indeterminate Colitis Price (2013-2018) 10.5 Others Sales Growth and Price 10.5.1 Global Others Sales Growth (2013-2018) 10.5.2 Global Others Price (2013-2018) 11 Global Inflammatory Bowel Disease Drugs Market Segment by Application 11.1 Global Inflammatory Bowel Disease Drugs Sales Market Share by Application (2013-2018) 11.2 Amino-salicylates Sales Growth (2013-2018) 11.3 Antibiotics Sales Growth (2013-2018) 11.4 Corticosteroids Sales Growth (2013-2018) 11.5 Immunomodulators Sales Growth (2013-2018) 11.6 Biologics Sales Growth (2013-2018) 11.7 Others Sales Growth (2013-2018) 12 Inflammatory Bowel Disease Drugs Market Forecast (2018-2023) 12.1 Global Inflammatory Bowel Disease Drugs Sales, Revenue and Growth Rate (2018-2023) 12.2 Inflammatory Bowel Disease Drugs Market Forecast by Regions (2018-2023) 12.2.1 North America Inflammatory Bowel Disease Drugs Market Forecast (2018-2023) 12.2.2 Europe Inflammatory Bowel Disease Drugs Market Forecast (2018-2023) 12.2.3 Asia-Pacific Inflammatory Bowel Disease Drugs Market Forecast (2018-2023) 12.2.4 South America Inflammatory Bowel Disease Drugs Market Forecast (2018-2023) 12.2.5 Middle East and Africa Inflammatory Bowel Disease Drugs Market Forecast (2018-2023) 12.3 Inflammatory Bowel Disease Drugs Market Forecast by Type (2018-2023) 12.3.1 Global Inflammatory Bowel Disease Drugs Sales Forecast by Type (2018-2023) 12.3.2 Global Inflammatory Bowel Disease Drugs Market Share Forecast by Type (2018-2023) 12.4 Inflammatory Bowel Disease Drugs Market Forecast by Application (2018-2023) 12.4.1 Global Inflammatory Bowel Disease Drugs Sales Forecast by Application (2018-2023) 12.4.2 Global Inflammatory Bowel Disease Drugs Market Share Forecast by Application (2018-2023) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source

List of Tables and Figures Figure Inflammatory Bowel Disease Drugs Picture Table Product Specifications of Inflammatory Bowel Disease Drugs Figure Global Sales Market Share of Inflammatory Bowel Disease Drugs by Types in 2017 Table Inflammatory Bowel Disease Drugs Types for Major Manufacturers Figure Ulcerative Colitis Picture Figure Crohns Disease Picture Figure Indeterminate Colitis Picture Figure Others Picture Figure Inflammatory Bowel Disease Drugs Sales Market Share by Applications in 2017 Figure Amino-salicylates Picture Figure Antibiotics Picture Figure Corticosteroids Picture Figure Immunomodulators Picture Figure Biologics Picture Figure Others Picture Figure United States Inflammatory Bowel Disease Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Canada Inflammatory Bowel Disease Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Mexico Inflammatory Bowel Disease Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Germany Inflammatory Bowel Disease Drugs Revenue (Value) and Growth Rate (2013-2023) Figure France Inflammatory Bowel Disease Drugs Revenue (Value) and Growth Rate (2013-2023) Figure UK Inflammatory Bowel Disease Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Russia Inflammatory Bowel Disease Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Italy Inflammatory Bowel Disease Drugs Revenue (Value) and Growth Rate (2013-2023) Figure China Inflammatory Bowel Disease Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Japan Inflammatory Bowel Disease Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Korea Inflammatory Bowel Disease Drugs Revenue (Value) and Growth Rate (2013-2023) Figure India Inflammatory Bowel Disease Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Southeast Asia Inflammatory Bowel Disease Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Brazil Inflammatory Bowel Disease Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Egypt Inflammatory Bowel Disease Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Saudi Arabia Inflammatory Bowel Disease Drugs Revenue (Value) and Growth Rate (2013-2023) Figure South Africa Inflammatory Bowel Disease Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Nigeria Inflammatory Bowel Disease Drugs Revenue (Value) and Growth Rate (2013-2023) Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors Table Abbott Laboratories Inflammatory Bowel Disease Drugs Type and Applications Table Abbott Laboratories Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Biocon Ltd Basic Information, Manufacturing Base and Competitors Table Biocon Ltd Inflammatory Bowel Disease Drugs Type and Applications Table Biocon Ltd Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table F. Hoffmann-La Roche AG Basic Information, Manufacturing Base and Competitors Table F. Hoffmann-La Roche AG Inflammatory Bowel Disease Drugs Type and Applications Table F. Hoffmann-La Roche AG Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Johnson and Johnson Basic Information, Manufacturing Base and Competitors Table Johnson and Johnson Inflammatory Bowel Disease Drugs Type and Applications Table Johnson and Johnson Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Mylan Pharmaceuticals Ltd. Basic Information, Manufacturing Base and Competitors Table Mylan Pharmaceuticals Ltd. Inflammatory Bowel Disease Drugs Type and Applications Table Mylan Pharmaceuticals Ltd. Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Novartis AG Basic Information, Manufacturing Base and Competitors Table Novartis AG Inflammatory Bowel Disease Drugs Type and Applications Table Novartis AG Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Pfizer Inc. Basic Information, Manufacturing Base and Competitors Table Pfizer Inc. Inflammatory Bowel Disease Drugs Type and Applications Table Pfizer Inc. Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Quest Medical, Inc. Basic Information, Manufacturing Base and Competitors Table Quest Medical, Inc. Inflammatory Bowel Disease Drugs Type and Applications Table Quest Medical, Inc. Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Sanofi S.A. Basic Information, Manufacturing Base and Competitors Table Sanofi S.A. Inflammatory Bowel Disease Drugs Type and Applications Table Sanofi S.A. Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors Table Takeda Pharmaceutical Inflammatory Bowel Disease Drugs Type and Applications Table Takeda Pharmaceutical Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Global Inflammatory Bowel Disease Drugs Sales by Manufacturer (2016-2017) Figure Global Inflammatory Bowel Disease Drugs Sales Market Share by Manufacturer in 2016 Figure Global Inflammatory Bowel Disease Drugs Sales Market Share by Manufacturer in 2017 Table Global Inflammatory Bowel Disease Drugs Revenue by Manufacturer (2016-2017) Figure Global Inflammatory Bowel Disease Drugs Revenue Market Share by Manufacturer in 2016 Figure Global Inflammatory Bowel Disease Drugs Revenue Market Share by Manufacturer in 2017 Figure Top 3 Inflammatory Bowel Disease Drugs Manufacturer (Revenue) Market Share in 2017 Figure Top 6 Inflammatory Bowel Disease Drugs Manufacturer (Revenue) Market Share in 2017 Figure Global Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) Figure Global Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2013-2018) Table Global Inflammatory Bowel Disease Drugs Sales by Regions (2013-2018) Table Global Inflammatory Bowel Disease Drugs Sales Market Share by Regions (2013-2018) Table Global Inflammatory Bowel Disease Drugs Revenue by Regions (2013-2018) Figure Global Inflammatory Bowel Disease Drugs Revenue Market Share by Regions in 2013 Figure Global Inflammatory Bowel Disease Drugs Revenue Market Share by Regions in 2017 Figure North America Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) Figure Europe Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) Figure Asia-Pacific Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) Figure South America Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) Figure Middle East and Africa Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) Figure North America Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2013-2018) Table North America Inflammatory Bowel Disease Drugs Sales by Countries (2013-2018) Table North America Inflammatory Bowel Disease Drugs Sales Market Share by Countries (2013-2018) Figure North America Inflammatory Bowel Disease Drugs Sales Market Share by Countries in 2013 Figure North America Inflammatory Bowel Disease Drugs Sales Market Share by Countries in 2017 Table North America Inflammatory Bowel Disease Drugs Revenue by Countries (2013-2018) Table North America Inflammatory Bowel Disease Drugs Revenue Market Share by Countries (2013-2018) Figure North America Inflammatory Bowel Disease Drugs Revenue Market Share by Countries in 2013 Figure North America Inflammatory Bowel Disease Drugs Revenue Market Share by Countries in 2017 Figure United States Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) Figure Canada Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) Figure Mexico Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) Figure Europe Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2013-2018) Table Europe Inflammatory Bowel Disease Drugs Sales by Countries (2013-2018) Table Europe Inflammatory Bowel Disease Drugs Sales Market Share by Countries (2013-2018) Table Europe Inflammatory Bowel Disease Drugs Revenue by Countries (2013-2018) Figure Europe Inflammatory Bowel Disease Drugs Revenue Market Share by Countries in 2016 Figure Europe Inflammatory Bowel Disease Drugs Revenue Market Share by Countries in 2017 Figure Germany Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) Figure UK Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) Figure France Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) Figure Russia Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) Figure Italy Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) Figure Asia-Pacific Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2013-2018) Table Asia-Pacific Inflammatory Bowel Disease Drugs Sales by Countries (2013-2018) Table Asia-Pacific Inflammatory Bowel Disease Drugs Sales Market Share by Countries (2013-2018) Figure Asia-Pacific Inflammatory Bowel Disease Drugs Sales Market Share by Countries 2017 Table Asia-Pacific Inflammatory Bowel Disease Drugs Revenue by Countries (2013-2018) Figure Asia-Pacific Inflammatory Bowel Disease Drugs Revenue Market Share by Countries 2017 Figure China Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) Figure Japan Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) Figure Korea Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) Figure India Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) Figure Southeast Asia Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) Figure South America Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2013-2018) Table South America Inflammatory Bowel Disease Drugs Sales by Countries (2013-2018) Table South America Inflammatory Bowel Disease Drugs Sales Market Share by Countries (2013-2018) Figure South America Inflammatory Bowel Disease Drugs Sales Market Share by Countries in 2017 Table South America Inflammatory Bowel Disease Drugs Revenue by Countries (2013-2018) Table South America Inflammatory Bowel Disease Drugs Revenue Market Share by Countries (2013-2018) Figure South America Inflammatory Bowel Disease Drugs Revenue Market Share by Countries in 2017 Figure Brazil Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) Figure Argentina Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) Figure Colombia Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) Figure Middle East and Africa Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2013-2018) Table Middle East and Africa Inflammatory Bowel Disease Drugs Sales by Countries (2013-2018) Table Middle East and Africa Inflammatory Bowel Disease Drugs Sales Market Share by Countries (2013-2018) Figure Middle East and Africa Inflammatory Bowel Disease Drugs Sales Market Share by Countries in 2017 Table Middle East and Africa Inflammatory Bowel Disease Drugs Revenue by Countries (2013-2018) Table Middle East and Africa Inflammatory Bowel Disease Drugs Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa Inflammatory Bowel Disease Drugs Revenue Market Share by Countries in 2013 Figure Middle East and Africa Inflammatory Bowel Disease Drugs Revenue Market Share by Countries in 2017 Figure Saudi Arabia Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) Figure UAE Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) Figure Egypt Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) Figure Nigeria Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) Figure South Africa Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018) Table Global Inflammatory Bowel Disease Drugs Sales by Type (2013-2018) Table Global Inflammatory Bowel Disease Drugs Sales Share by Type (2013-2018) Table Global Inflammatory Bowel Disease Drugs Revenue by Type (2013-2018) Table Global Inflammatory Bowel Disease Drugs Revenue Share by Type (2013-2018) Figure Global Ulcerative Colitis Sales Growth (2013-2018) Figure Global Ulcerative Colitis Price (2013-2018) Figure Global Crohns Disease Sales Growth (2013-2018) Figure Global Crohns Disease Price (2013-2018) Figure Global Indeterminate Colitis Sales Growth (2013-2018) Figure Global Indeterminate Colitis Price (2013-2018) Figure Global Others Sales Growth (2013-2018) Figure Global Others Price (2013-2018) Table Global Inflammatory Bowel Disease Drugs Sales by Application (2013-2018) Table Global Inflammatory Bowel Disease Drugs Sales Share by Application (2013-2018) Figure Global Antibiotics Sales Growth (2013-2018) Figure Global Corticosteroids Sales Growth (2013-2018) Figure Global Immunomodulators Sales Growth (2013-2018) Figure Global Biologics Sales Growth (2013-2018) Figure Global Others Sales Growth (2013-2018) Figure Global Inflammatory Bowel Disease Drugs Sales, Revenue and Growth Rate (2018-2023) Table Global Inflammatory Bowel Disease Drugs Sales Forecast by Regions (2018-2023) Table Global Inflammatory Bowel Disease Drugs Market Share Forecast by Regions (2018-2023) Figure North America Sales Inflammatory Bowel Disease Drugs Market Forecast (2018-2023) Figure Europe Sales Inflammatory Bowel Disease Drugs Market Forecast (2018-2023) Figure Asia-Pacific Sales Inflammatory Bowel Disease Drugs Market Forecast (2018-2023) Figure South America Sales Inflammatory Bowel Disease Drugs Market Forecast (2018-2023) Figure Middle East and Africa Sales Inflammatory Bowel Disease Drugs Market Forecast (2018-2023) Table Global Inflammatory Bowel Disease Drugs Sales Forecast by Type (2018-2023) Table Global Inflammatory Bowel Disease Drugs Market Share Forecast by Type (2018-2023) Table Global Inflammatory Bowel Disease Drugs Sales Forecast by Application (2018-2023) Table Global Inflammatory Bowel Disease Drugs Market Share Forecast by Application (2018-2023) Table Distributors/Traders/ Dealers List

Abbott Laboratories Biocon Ltd F. Hoffmann-La Roche AG Johnson and Johnson Mylan Pharmaceuticals Ltd. Novartis AG Pfizer Inc. Quest Medical, Inc. Sanofi S.A. Takeda Pharmaceutical